Editas Medicine (EDIT) Enterprise Value (2015 - 2025)
Editas Medicine (EDIT) posted quarterly Enterprise Value of -$146.6 million for Q4 2025, up 45.67% year-over-year from -$100.7 million in Q4 2024, and up 11.47% quarter-over-quarter from -$165.6 million in Q3 2025.
Editas Medicine (EDIT) Enterprise Value (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has reported Enterprise Value for 11 consecutive years, with -$146.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Enterprise Value rose 45.67% year-over-year to -$146.6 million; the TTM figure through Dec 2025 stood at -$146.6 million (up 45.67% YoY), while the FY2025 annual figure was -$146.6 million, up 45.67% from the prior year.
- Enterprise Value rose to -$146.6 million in Q4 2025 per EDIT's latest filing, from -$165.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$146.6 million in Q4 2025 and bottomed at -$625.3 million in Q1 2021.
- Historically, Enterprise Value has averaged -$362.2 million across 5 years, with a median of -$333.7 million in 2022.
- Annual changes were most pronounced in 2021 — Enterprise Value sank 50.69% — and 2025, when it soared 45.67%.
- Editas Medicine's Enterprise Value stood at -$499.8 million in 2021, then jumped by 31.12% to -$344.3 million in 2022, then increased by 6.15% to -$323.1 million in 2023, then rose by 16.46% to -$269.9 million in 2024, then jumped by 45.67% to -$146.6 million in 2025.
- Business Quant data shows EDIT's Enterprise Value at -$146.6 million in Q4 2025, -$165.6 million in Q3 2025, and -$178.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Editas Medicine | 263.01 Mn | 116.36 Mn | - | -146.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -146.65 Mn |
| Sep 30, 2025 | -165.65 Mn |
| Jun 30, 2025 | -178.50 Mn |
| Mar 31, 2025 | -220.96 Mn |
| Dec 31, 2024 | -269.91 Mn |
| Sep 30, 2024 | -265.09 Mn |
| Jun 30, 2024 | -279.11 Mn |
| Mar 31, 2024 | -296.17 Mn |
| Dec 31, 2023 | -323.11 Mn |
| Sep 30, 2023 | -349.62 Mn |
| Jun 30, 2023 | -431.97 Mn |
| Mar 31, 2023 | -318.44 Mn |
| Dec 31, 2022 | -344.27 Mn |
| Sep 30, 2022 | -419.62 Mn |
| Jun 30, 2022 | -452.56 Mn |
| Mar 31, 2022 | -488.36 Mn |
| Dec 31, 2021 | -499.85 Mn |
| Sep 30, 2021 | -557.84 Mn |
| Jun 30, 2021 | -610.55 Mn |
| Mar 31, 2021 | -625.33 Mn |